European regulators approve Amgen cancer drug Kyprolis
Thousand Oaks-based Amgen scored another major victory Nov. 19. European regulators approved experimental drug Kyprolis on Thursday for patients who have received at least one prior treatment for multiple-myeloma. Kyprolis was the cornerstone of Amgen’s $10.4 billion buyout of Onyx Pharmaceuticals in 2013. Multiple-myeloma is a form of blood cancer that forms in plasma cells Read More →
Teledyne sales dropped in third quarter
Sales slumped once again for Teledyne Technologies in the third quarter. The Thousand Oaks-based industrial conglomerate said it saw sales decline for the third straight quarter when it released third quarter earnings on Oct. 29. Sales fell 7.6 percent from $601.1 million during the third quarter of 2014 to $555.4 million this year. Because of Read More →
Inphi third quarter earnings beat analyst estimates
Inphi Corp. beat analyst estimates by a penny when the company released third quarter earnings on Oct. 27. The Santa Clara-based company, which designs chips aimed at packing more memory onto Internet servers and increasing bandwidth, employs a large engineering force in Thousand Oaks. Inphi Corp. earnings were 25 cents per share, one cent greater Read More →
Chinese have yuan for Conejo Valley
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Ryland Group’s Westlake office to close in 2016 due to merger
The Ryland Group office in Westlake Village will close in 2016 following the company’s merger with Standard Pacific Homes. Homebuilders Ryland and Irvine-based Standard Pacific recently completed a $5.2-billion merger to create CalAtlantic Group, the nation’s fourth largest residential home developer. Larry Nicholson, former CEO of Ryland, will serve as CEO of the new Read More →
